Jacquelyn Campbell is a national leader in research and advocacy in the field of domestic violence or intimate partner violence (IPV). Her expertise is frequently sought by national and international policy makers in exploring IPV and its health effects on families and communities.
Her most recent research in health sequelae has been foundational for the areas of the intersection of HIV and violence against women and how head injuries and strangulation from intimate partner violence can result in undiagnosed and untreated Traumatic Brain Injury. She has consistently advocated for addressing health inequities of marginalized women in this country and globally affected by experiences of violence.
She has served as Principle Investigator on 14 federally funded collaborative research investigations through the National Institutes of Health, National Institutes of Justice, Department of Defense, the Department of Justice (Office of Violence Against Women), and Centers for Disease Control to examine intimate partner homicide and other forms of violence against women as well as interventions and policy initiatives to improve the justice and health care system response. This work has paved the way for a growing body of interdisciplinary knowledge about experiences of violence and health outcomes, risk assessment for lethal and near-lethal domestic violence, and coordinated system (justice, social services, and health) responses to address intimate partner violence.
Dr. Campbell has published more than 270 articles, 56 book chapters and seven books, in addition to developing the Danger Assessment, an instrument to assist abused women in accurately determining their level of danger. The Danger Assessment is also the basis of the Lethality Assessment Program (MNADV LAP) for first responders to assess risk of homicide of domestic violence survivors and connect those at high risk with domestic violence services. In collaboration with Dr. Nancy Glass, originator of myPlan, a decision aid for IPV survivors, she is leading an NIH-funded cultural adaptation of myPlan for immigrant and indigenous women.
Elected to the Institute of Medicine in 2000, Dr. Campbell also was the Institute of Medicine/American Academy of Nursing/American Nurses' Foundation Senior Scholar in Residence and was founding co-chair of the IOM Forum on the Prevention of Global Violence. Other honors include the Pathfinder Distinguished Researcher by the Friends of the National Institute of Health National Institute for Nursing Research, Outstanding Alumna and Distinguished Contributions to Nursing Science Awards, Duke University School of Nursing, the American Society of Criminology Vollmer Award, and being named one of the inaugural 17 Gilman Scholars at Johns Hopkins University. She is on the Board of Directors for Futures Without Violence, is an active member of the Johns Hopkins Women’s Health Research Group, and has served on the boards of the House of Ruth Battered Women's Shelter and four other shelters. She was a member of the congressionally appointed U.S. Department of Defense Task Force on Domestic Violence.
We need to enforce the gun laws we already have that keep guns out of the hands of known domestic violence offenders and we need to more carefully explore the link between mass shootings and domestic violence.
“Domestic violence homicides have gone down. But clearly from the data they have gone down, in part, in great part, because of the gun restrictions that were put on known domestic violence offenders.” ,“So often, when a victim reports the alleged perpetrator, it becomes a he-said, she-said or he-said, he-said. If we did a better job in documenting those injuries we would have an additional source around consent."
Beaches, lakes, and pools are great ways to beat the heat but there are precautions to take before reaching for that swimsuit, said Gabriella Cardone, MD, an emergency medicine pediatrician with McGovern Medical School at UTHealth and attending physician at Children’s Memorial Hermann Hospital. “Taking the time to follow some basic precautions will keep you and your loved ones safe in the water all summer long,” Cardone said. Before engaging in aquatic activities, make sure everyone knows how to swim or has an approved life jacket. Water noodles, inner tubes, or water wings do not count. Tragically, there are approximately 3,536 fatal unintentional drownings in the U.S. every year, which is an average of 10 deaths a day, according to the Centers for Disease Control and Prevention. “Children should learn how to swim by age 4 and their parents should learn cardiopulmonary resuscitation or CPR in case of emergency,” Cardone said.
Arianne Cease is a sustainability scientist who works to understand how human-plant-insect interactions affect the sustainability of agricultural systems.
A major focus is on locust plagues and phenotypic plasticity in response to agricultural practices in China, Australia, West Africa and South America. She investigates the interactions among human behavior, market forces, and ecological systems in situations in which human decisions to overstock and overgraze rangeland alter plant nutrient content, increasing the likelihood of locust outbreaks. A key goal of her research is to improve sustainable ecosystem management and rural livelihoods.
Cease is an assistant professor in the School of Sustainability and the School of Life Sciences. She is also director of ASU’s Global Locust Initiative.
"In general, locust outbreaks are expected to become more frequent and severe under climate change."
Anees is the Director of The Breast Center, Smilow Cancer Hospital at Yale-New Haven, an Associate Professor in the Department of Surgery, Yale School of Medicine, and the Assistant Director for Global Oncology at Yale Comprehensive Cancer Center. Born and
"Three-dimensional mammography can help detect more cancers earlier and reduce call-back rates."
Sumit Chanda, Ph.D., is a virologist at Sanford Burnham Prebys Medical Discovery Institute who is racing to find a treatment for COVID-19.
His team is testing 13,000 compounds for effectiveness against SARS-CoV-2, leveraging a library created with the support of the Bill & Melinda Gates Foundation called the ReFRAME drug repurposing collection. All of the drugs tested are already approved by the FDA for another disease or have been tested extensively for human safety.
Prior to the outbreak, Chanda’s lab was advancing broad-spectrum antivirals—medicines that would work against many viruses, not just one—that could protect us against a pandemic.
Chang's work focuses on the therapy resistance of cancer stem cells, which has led to several publications and international presentations. Her clinical research aims to evaluate novel biologic agents in breast cancer patients. Chang has worked in the field of tumor-initiating cells for more than 10 years. After her discovery that tumor-initiating cells are chemo-resistant, and that targeting the EGFR/HER2 pathway can decrease this subpopulation, Chang played a key role in demonstrating some of the limitations and mechanisms of tumor-initiating cells. Her work is now focused on the mechanisms that regulate TICs, as well as initiating and planning clinical trials that target this critical tumor initiating subpopulation. She is also interested in characterizing the cross-talk between these different pathways that may lead to mechanisms of resistance, and has identified some of the chief regulatory pathways involved in TIC self-renewal. She is a world-renown clinical investigator, credited as one of the first to describe intrinsic chemo-resistance of tumor-initiating cells.
Bernard (Bernie) W. Chang, M.D., Director of Baltimore’s Plastic & Reconstructive Surgery at Mercy, also leads The Breast Reconstruction and Restoration Center at Mercy. Dr. Bernie Chang is Board Certified in Plastic Surgery and General Surgery. He pioneered and advanced surgical treatment options like DIEP flap surgery for breast reconstruction. With a skilled and highly specialized team of doctors, Mercy's Plastic Surgery and Breast Reconstruction Centers are known as one of the Mid-Atlantic’s best in breast reconstruction and restoration, cosmetic medicine and plastic surgery.
As the Assistant Director of The Hoffberger Breast Center at Mercy in Baltimore, Dr. Bernie Chang works closely with the Breast Center doctors to provide seamless care for those women who choose immediate breast reconstruction after breast surgery. The industry-leading expertise of Dr. Chang and the renowned reputation of the physicians of The Breast Center result in choices that women may not find elsewhere.
With more than 20 years of medical experience, Dr. Chang offers women peace of mind in breast reconstruction and restoration. His quiet thoughtfulness and attention to the needs of his patients provide a calming touch that helps each woman focus on her treatment options and recovery. His expertise is in helping women reclaim their feminine form and personal self-esteem after a diagnosis and treatment for breast cancer. Women say they have regained their physical and emotional balance in the care of Dr. Chang.
Dr. Chang has performed DIEP flap breast reconstruction surgery for decades and his leadership is widely known. DIEP flap breast reconstruction surgery is one of the most widely performed breast shaping options for women. Dr. Chang is also skilled in other microsurgical flap procedures including:
SGAP flap & Bilateral SGAP Flap
Dr. Bernie Chang’s surgical expertise attracts surgical fellows from across the nation to train in the renowned Fellowship Program at Mercy in breast reconstruction and surgical flap treatment options.
Jennifer Chatman is a world-renowned researcher, teacher & consultant on leveraging organizational culture for firm performance and leading high-performance teams.
Chatman is the Paul J. Cortese Distinguished Professor of Management and a faculty member in the Management of Organizations (MORS) Group at Berkeley Haas. In her research, teaching, and consulting work, she focuses on how organizations can leverage culture for strategic success and how diverse teams can optimize performance. Her award-winning research has shown, for example, how emphasizing innovation in the context of a strong culture increases firms’ financial success, how narcissistic leaders create organizational cultures lower in collaboration and integrity, and how norms to cooperate can cause members to blur differences among them, even if those differences are useful for group performance—suggesting that collaboration should be calibrated in diverse teams.
Chatman is the Co-Director of the Berkeley Culture Initiative, the Assistant Dean for Learning Strategies at the Haas School of Business, an Editor for the journal Research in Organizational Behavior, and runs the Leading High Performance Cultures executive education program. She has served in many other leadership roles at Haas and UC Berkeley over the years. Chatman earned her PhD at Berkeley Haas, and her BA in Psychology from UC Berkeley.
“We have a hard time distinguishing the features that make for a good leader from the features that are associated with narcissism. The whole point of an organization is to try to do something together”.,"Getting people to join a multilevel marketing company usually involves a small initial hurdle, maybe they have some success selling a little bit and they buy a little bit more. So there's a kind of escalation cycle that occurs".,"Jargon masks real meaning. People use it as a substitute for thinking hard and clearly about their goals and the direction that they want to give others".
Triple board-certified in internal medicine, hematology and medical oncology, Dr. Mohamad Cherry is medical director of Hematology at Atlantic Health System Cancer Care. He joined Atlantic Hematology Oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center, bringing years of clinical knowledge and expertise.
With specialty training from some of the nation's most skilled clinicians, Dr. Cherry attained some of his clinical training at the leukemia department at MD Anderson and his fellowship in hematology/oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He performed two residencies - an internal medicine residency at Staten Island University Hospital and a laboratory medicine residency at the American University of Beirut Medical Center in Lebanon. Previously, Dr. Cherry attained his medical degree at Lebanese University and performed his internship at Sacre Coeur Hospital-Lebanese University. He also earned a master of science degree in clinical and translational research from University of Oklahoma College of Public Health.
Dr. Cherry remains on staff as clinical associate professor of hematology/oncology at University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He is also the director of its hematology/oncology fellowship program and co-chairs the Academy of Teaching Scholars Faculty Development, Education and Mentoring Committee. Other administrative roles include co-chair of the leukemia working group at the Sarah Cannon Research Institute Blood Cancer Consortium.
As a principal investigator of multiple clinical trials, Dr. Cherry has performed groundbreaking research in niche areas that include epigenetics and development of new therapeutics in relapsed and refractory blood cancers. He has developed teaching materials and book chapters, and has lectured both nationally and internationally.
Dr. Cherry continues to serves as a mentor and an advisor to fellows, residents and medical students. He contributes to continuing education, public health, and professional development, and has won awards and funding for both his research and his clinical pursuits.
Henry Chesbrough, who coined the term “open innovation,” is faculty director of the Garwood Center for Corporate Innovation at Berkeley Haas. His research focuses on technology management and innovation strategy. He also teaches at Esade Business School at Spain’s University Ramon Llull. He has been an adjunct professor at the Harvard Business School and previously served as product manager and vice president of marketing at Quantum Corporation, a manufacturer of data storage devices and systems. He earned a BA in economics from Yale University, an MBA from Stanford University, and a PhD in business administration from Berkeley Haas.
Open innovation is a paradigm that assumes that firms can and should use external and internal ideas and paths to market to advance their technology. The central idea behind open innovation is that—in a world of widely distributed knowledge where the boundaries between a firm and its environment have become more permeable—companies cannot afford to rely entirely on their own research but should instead buy or license processes or inventions from other companies. In addition, internal inventions not being used in a firm’s business should be taken outside the company (e.g., through licensing, joint ventures, spin-offs).
The development of an openly innovative approach means that companies can be spun off from large corporates or they can emerge independently. The open innovation model results in a more profitable route to innovation. This is due in the main to reduced costs, accelerated time to market and increased market differentiation.,One of the key elements of open innovation is collaboration. By seeking out external partners with capabilities that complement and synergise with their inhouse expertise, business owners can move more quickly to plug gaps in their value chain, develop better products and services, colonise a niche in existing markets, and even expand into new markets. Read more from Asian Scientist Magazine at: https://www.asianscientist.com/2018/10/features/ipi-singapore-innovate-collaborate-research-development/
Christina Chin is anticipating the Aug. 15 opening of the romantic comedy “Crazy Rich Asians” and the insights the film offers into the Asian American second-generation experience.
The film, based on the book of the same name by Kevin Kwan, is the first from a major Hollywood studio to feature an entirely Asian cast in a present-day story since the release 25 years ago of “The Joy Luck Club.”
Chin, who has previewed the film, notes that the story it tells goes beyond money and wealth to highlight universal themes about love, friendship and negotiating family dynamics “that transcend ethnic and racial boundaries.”
The assistant professor of sociology is co-author of a widely reported 2017 study “Tokens on the Small Screen” about how Asian Americans and Pacific Islanders remain underrepresented on television. She and scholars from five other universities collaborated on the study, a 10-year follow-up to and expansion of an earlier study of Asian Americans and Pacific Islanders on prime-time series television.
Chin’s teaching and scholarly research interests include immigration, racial and ethnic identity, youth and popular culture. Chin is co-editor of "Asian American Sporting Cultures" (NYU Press -2016). Chin earned her doctorate at UCLA. Prior to joining the Cal State Fullerton faculty, she was a postdoctoral fellow for the Asian American Studies Department at the University of Illinois, Urbana-Champaign.
“This feeling of being an outsider in both worlds not only struck a deep personal cord in my own lived experience, but it could not be captured in a film with white actors.”,"With successful shows like “Master of None" & "Fresh Off the Boat” ... it may seem that Asian Americans are making greater strides on TV. Yet, when we take a deeper look at the larger TV landscape, we start to see that these shows are the exception ...”
Andrew Ching is a professor in the Carey Business School at the Johns Hopkins University, where he is jointly appointed to the Department of Economics and the Bloomberg School of Public Health. He is currently serving as an Associate Editor for Management Science, and a member of editorial boards for Marketing Science and Journal of Marketing Research. His research focuses on developing new empirical structural models and estimation methods to understand the forward-looking, strategic, learning and bounded rational behavior of consumers and firms. He has applied these methods to several industries including prescription drugs, nursing homes, payment methods, retail banking, peer-to-peer lending, and video games. He has published in Econometrica, Mangement Science, Marketing Science, Journal of Banking and Finance, Journal of Applied Econometrics, and others. He has received Young Economist Award from the European Economic Association, Honorable Mention of Dick Wittink Prize Award, and several major research grants from Social Sciences and Humanities Research Council in Canada.
Dr. Jerold Chun is professor and senior vice president of Neuroscience Drug Discovery at SBP. He completed his M.D. and Ph.D. degrees at Stanford University. He studies development and diseases of the brain.
“Our fundamental studies of how the brain develops and changes over time have opened up two totally new ways of looking at neurological disease, and we’re hopeful that will lead to better treatments for Alzheimer’s, multiple sclerosis and hydrocephalus.”
Colleen Cicchetti, PhD, is a pediatric psychologist at Ann & Robert H. Lurie Children's Hospital of Chicago and an Assistant Professor in Psychiatry and Behavioral Sciences at Northwestern University Feinberg School of Medicine. She is the Executive Director of the Lurie Children's Center for Childhood Resilience, which promotes access to high quality mental health services for children and adolescents statewide through clinical service, research, training, advocacy, and policy reform. She is a leader in trauma-informed care, training staff in the Chicago Public Schools on how to help youth who have experienced trauma or have other mental health issues. She was awarded the Public Educator of the Year award by the National Alliance on Mental Illness.
M. Dolores Cimini is a New York State licensed psychologist who has provided leadership for comprehensive efforts in research-to-practice translation at the University at Albany since 1992 with over $9 million in support from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institute on Drug Abuse (NIDA), Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Education, U.S. Department of Justice, and New York State Office of Addiction Services and Supports. The screening and brief intervention program developed by Dr. Cimini, the STEPS Comprehensive Alcohol Screening and Brief Intervention Program, has earned 13 national awards for best practices and innovation in behavioral health care.
Cimini is the director of the Middle Earth Peer Assistance Program at UAlbany, an agency recognized as a model/exemplary program in alcohol and other drug prevention by both the U.S. Department of Education and the Center for Substance Abuse Prevention, U.S. Department of Health and Human Services. She has published two books and numerous professional articles in both national and international refereed journals in the alcohol and substance use field and has earned two awards for excellence from the White House for her contributions to STEM mentoring. Cimini is a member of the Commission on Accreditation of the American Psychological Association and was the Past Chair of the APA Board for the Advancement of Psychology in the Public Interest, where she has had leadership for reviewing and disseminating APA’s practice standards focused on serving diverse and underrepresented groups and the addressing of issues related to psychology and social justice.
"It's so important for a project like this to occur, focusing on secondary education because how people intervene with young people at this age can really impact the rest of their lives."
Dr. Dolores Cimini says college students engage in high risk drinking and drug use, to a large extent, due to peer pressure. Cimini, says students are also experiencing freedom from their parents for the first time.
Joseph J. Ciotola, M.D., is a top rated orthopedic surgeon at Orthopedics and Joint Replacement at Mercy Medical Center. Board Certified, Dr. Ciotola’s extensive expertise in anterior hip replacement makes him one of the most sought-after orthopedic surgeons in the Baltimore region for hip replacement.
Dr. Ciotola also specializes in knee replacement and knee resurfacing using MAKO® robotic arm technology, ACL reconstruction and shoulder/upper extremity surgeries including total shoulder replacement and the LRTI procedure to relieve arthritis of the thumb.
Dr. Joseph Ciotola’s dedication to providing advanced orthopedic techniques helped bring anterior hip replacement to Orthopedics and Joint Replacement at Mercy. Dr. Ciotola, who is one of the first orthopedic surgeons in Baltimore to perform anterior hip replacement, teaches orthopedic surgeons throughout the country how to perform this minimally invasive approach to hip replacement. Many of his patients have expressed their gratitude and satisfaction by recommending Dr. Ciotola to family, friends and even strangers who are in need of a hip replacement.
Dr. Joseph Ciotola is dedicated to providing his patients the best orthopedic care possible. Patients turn to Dr. Ciotola for his clinical expertise when they have hip or knee pain. His great compassion and concern for helping relieve their pain provides patients with the confidence that they will be able to return to their daily routines. Dr. Ciotola works individually with patients to develop the best treatment options to help with the return to normal activities.
Bioethics, Safe Injection Sites, End Of Life Ethics, Health Care Reform, Catholic Bioethics, Healthcare Management and Religion, Beginning Of Life Issues, Assisted Reproductive Technologies, public health issues, Organ Transplantation, Medical Futility
Peter A. Clark, S.J., Ph.D. is Director of the Institute of Clinical Bioethics and Professor of Medical Ethics at Saint Joseph's University. As an internationally known scholar and clinical bioethicist, he has authored more than 150 journal articles and several books in the field of medical ethics and bioethics, and played an influential role in developing and updating healthcare ethics policies at healthcare organizations and ethics education for medical interns and residents at teaching hospitals. Fr. Clark is a bioethics consultant and a member of ethics committees at many hospitals, including, St. Christopher's Hospital for Children, Jefferson Health Northeast-Torresdale Hospital, Frankford Hospital, Lower Bucks Hospital, Abington Hospital, Trinity East Health System, Mercy Hospital, Mercy Fitzgerald Hospital, Nazareth Hospital, St. Mary's Medical Center, St. Francis Hospital, Catholic Charities of Maryland, Saint Agnes Hospital and Caritas Baby Hospital in Palestine.
Areas of expertise: Catholic bioethics, safe injection sites, end-of-life issues, health care management, religion and health care reform, beginning-of-life issues, medical futility, organ transplantation, assisted reproductive technologies, public health issues
Dr. Nathaniel Cline can speak to a broad scope of economic topics, including the impact of new laws going active Jan. 1, 2020. He holds a Ph.D. in economics and is a recognized expert on economic history, the U.S. and international macroeconomics, Bitcoin, Brexit, and international finance.
Cosimo Commisso, Ph.D., studies pancreatic cancer, one of the deadliest cancers. He is particularly interested in how the tumor gets nutrients from its environment, as cutting this fuel supply could stop the cancer’s growth.